President-elect Joe Biden will target his office when he holds the second half of US vaccine production to ensure that the second dose can be a breakthrough in the Trump administration’s strategy to release every available dose of coronavirus vaccine.
what does this mean: The release of more current doses of vaccine will allow more people to get the first dose of vaccine, thereby rapidly increasing the utilization of coronavirus vaccines. Since Pfizer/BioNTech and Moderna̵
“The president-elect believes that we must speed up vaccine distribution while continuing to ensure that Americans who need it most need it as soon as possible. He supports the immediate release of available doses and believes that the government should stop obstructing vaccine supply, so we can now be in the arms of Americans It was shot in the middle,” Biden’s Transition Spokesperson TJ Ducklo said. “He will share more details next week on how his government will begin to release usable doses when it takes office on January 20.”
Biden made the above comments during the transition period when a group of governors wrote to the Secretary of Health and Human Services Alex Azar and Gustav Perner, Chief Operating Officer of Speed of Operations. General (Gustave Perna) urged the federal government to distribute “reserved doses” of the Covid-19 vaccine to countries that require them.
“Our states are ready to work around the clock to expand the scope of distribution, increase weapon shooting, and save more American lives. As you said before, General Perna said,’vaccine on the shelf is not effective’,” Xinread . “We can no longer reach a consensus with you. That is why we are now seeking your help. When we work together, we can end this pandemic and return to normal life as soon as possible.”
The Trump administration insists that it is necessary to reduce the dose to ensure that Americans who receive the first two doses of the vaccine will get the second dose. But this move has sparked a debate about whether a better strategy will release all available doses as soon as possible, especially as death and hospitalization rates are rising. A study published in the Annals of Internal Medicine on Monday also found that administering the first dose of the Covid-19 vaccine to more people instead of retaining the available supply of the second dose can reduce the number of new cases.
A spokesperson for the Ministry of Health and Human Services said: “Operation Warp Speed will continue to ensure that the second dose of vaccine is provided to vaccination sites at appropriate intervals as instructed by the leadership of the jurisdiction.” “We are pleased to learn that the jurisdiction has actually Much more than the dose currently reported. We encourage jurisdictions to expand their priority groups as needed to ensure that no vaccine locations are put on hold after the vaccine is delivered to the jurisdiction.”
The spokesperson also pointed out that the US Food and Drug Administration recently reiterated the importance of both Pfizer and Hyundai vaccines requiring two injections.
More information about vaccines: After two full doses, both Pfizer/BioNTech and Moderna’s vaccines are about 95% effective.
Earlier this week, two senior FDA officials said that anyone receiving these vaccines would need two doses, and abandoned the idea of only allowing one dose or halving the dose to extend the supply.
They also refuted other ideas for expanding the supply of vaccines, saying that people who are speculating about the possibility of using only one dose or halving the dose are misunderstanding the data.
“We have been paying attention to discussions and news reports about reducing the number of doses, extending the interval between doses, changing the dose (half dose) or mixing and matching vaccines in order to make more people immune to COVID-19, Stephen, head of the FDA vaccine department Dr. Hahn and Dr. Peter Marks said in a statement.
“These are reasonable questions to be considered and evaluated in clinical trials. However, at present, it is too early to suggest that changes to the FDA-authorized doses or schedules of these vaccines are too early to take root in existing evidence. There is no appropriate data. In support of such changes, in terms of vaccine management, we risked putting public health at risk and undermined historic vaccination efforts to protect people from COVID-19.”
Hahn and Max also stated that the data supports the second dose of each vaccine in the specified time interval-21 days after the first injection of Pfizer/BioNTech vaccine, and 28 days after the first injection of Moderna vaccine.
According to a study published on Monday in the Annals of Internal Medicine, by reducing the vaccine dose withheld in the first three weeks to 10%, and stably providing 6 million doses per week, the United States can avoid up to 29 cases in eight weeks. %.
The US government currently withholds 50% of the available vaccine supply and distributes it to states and other jurisdictions in a few weeks for administration as the second dose in a two-dose series.
The researchers modeled various scenarios with variables including vaccine supply, the protection provided by the first dose of vaccine, and the reduced efficacy of the first dose if the second dose was delayed. The model only shows that withholding 50% of the available supply will provide more protection only in the unlikely worst-case scenario, that is, when there is a short supply in the individual receiving the first dose of the drug, and the protection provided is very little. Good protection.
“We have found that in the most feasible case, a more balanced approach is to not vaccinate less vaccines during the early distribution period, so that more people can be vaccinated as soon as possible, which can greatly improve the effectiveness of the vaccine while making Most recipients are able to receive the second dose of the vaccine as planned.” The authors of the study wrote a letter with support from the Canadian Institutes of Health Research and the US Centers for Disease Control and Prevention.